Influence of methylprednisolone on plasma homocysteine levels in cadaveric renal transplant recipients.
The aim of the present study was to investigate plasma homocysteine levels in renal transplant recipients in the course of steroid-based or steroid-free immunosuppression. Data from 32 patients were retrospectively analyzed according to the steroid immunosuppressive regimen. The 20 recipients on methylprednisolone (MP) plus cyclosporine (CyA) or tacrolimus (TRL) (n = 20) showed similar creatinine levels when compared with those on calcineurin inhibitors plus mycophenolate mofetil (MMF; n = 12), (1.6 +/- 1.5 vs 1.6 +/- 0.4 mg/dL; P = NS) but significantly higher total plasma homocysteine (tHcy) levels (28.5 +/- 12.5 vs 16.3 +/- 5.5 micromol/L; P < .05). No differences of tHcy levels have been observed when patients were analyzed according to CyA- or TRL-based immunosuppression regardless of MP or MMF associations. Our data suggest that recipients, particularly those on steroid-based immunosuppression, should receive homocysteine-lowering treatment early after transplantation.
Libetta
C
C
Fondazione IRCCS Policlinico San Matteo, Pavia, Italy.
Sepe
V
V
Zucchi
M
M
Pisacco
P
P
Portalupi
V
V
Adamo
G
G
Soccio
G
G
Dal Canton
A
A
D000328:Adult; D000368:Aged; D002102:Cadaver; D004359:Drug Therapy, Combination; D005260:Female; D005938:Glucocorticoids / Q000627:therapeutic use; D006710:Homocysteine / Q000097:blood*; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D016030:Kidney Transplantation / Q000276:immunology / Q000502:physiology*; D008297:Male; D008775:Methylprednisolone / Q000627:therapeutic use*; D008875:Middle Aged; D012189:Retrospective Studies; D014019:Tissue Donors
D005938:Glucocorticoids; D007166:Immunosuppressive Agents; D006710:Homocysteine; D008775:Methylprednisolone